Cell fate choices by Tbx1 in forming the mammalian heart
Tbx1 在形成哺乳动物心脏过程中的细胞命运选择
基本信息
- 批准号:10451598
- 负责人:
- 金额:$ 60.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-20 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:22q1122q11.23-DimensionalAPLN geneATAC-seqAffectAllelesAnteriorAortaBindingBinding ProteinsBinding SitesBiological ProcessCardiacCardiac developmentCell Differentiation processCell modelCellsChIP-seqChromatinChromosomesDataData SetDefectDiGeorge SyndromeEctopic ExpressionEmbryoEmbryonic DevelopmentFaceGene Expression ProfileGene ProteinsGeneral PopulationGenesGeneticGenetic TranscriptionHeartHeart AbnormalitiesHuman GeneticsImmunofluorescence ImmunologicIndividualLungMammalsMapsMesenchymeMesodermMesoderm CellMolecularMusMuscleMuscle FibersMutant Strains MiceMutationMyocardiumNeckNeonatalPathway interactionsPatientsPenetrancePersistent Truncus ArteriosusPharyngeal ApparatusPhenocopyPopulationPopulation SizesProcessRegulatory ElementRisk FactorsShprintzen syndromeTestingTimeTissuesbasecell behaviorcell typeconditional mutantcongenital heart disorderembryo tissueexperimental studyfunctional genomicsgastrulationgene networkinterestmouse modelmutantprecursor cellprogenitorprogramsreceptorsingle-cell RNA sequencingspatiotemporalstem cellstranscription factortranscriptomics
项目摘要
TBX1 encodes a T-box transcription factor required for cardiac development. This gene maps to
the chromosome 22q11.2 region that is deleted in patients with DiGeorge syndrome/velo-cardio-
facial syndrome or 22q11.2 deletion syndrome (22q11.2DS). Approximately 60% of 22q11.2DS
patients have congenital heart disease that mostly affects the cardiac outflow tract. A subset of
individuals with a mutation of the TBX1 gene but not a deletion has been identified and they
partially phenocopy patients with 22q11.2DS. Inactivation of one allele of Tbx1 in mice results in
mild defects, but inactivation of both alleles results in neonatal lethality with a persistent truncus
arteriosus, in which the aorta and pulmonary trunk fail to separate. This defect also occurs in 5-
10% of 22q11.2DS patients with congenital heart disease. To understand the function of Tbx1 in
mammals, we performed single cell RNA-sequencing (scRNA-seq) of cardiopharyngeal
mesoderm progenitor cells within the pharyngeal apparatus. We discovered a multilineage
progenitor (MLP) population that expresses genes important for forming the cardiac outflow tract
as well as branchiomeric muscles of the face and neck. The MLP population expands at the
expense of more differentiated populations when Tbx1 is inactivated in the cardiopharyngeal
mesoderm. Our main hypothesis is that Tbx1 is required in the MLP population for progression
towards more differentiated states needed for cardiac development. We propose three specific
aims to test this hypothesis. In the first aim, we will perform additional scRNA-seq experiments
and analyze the complete dataset to understand how the progression of MLP cells are altered in
Tbx1 conditional and global mutant mouse embryos. In Aim 2, we will determine where the MLP
cells are localized in the embryo. Preliminary data suggests that these cells are localized to the
nascent mesenchyme of the elongating pharyngeal apparatus. We will also inactivate Tbx1
specifically within the MLP cells to determine its particular functions. In Aim 3, we will turn to
functional genomic studies and will identify open and accessible chromatin for which harbors
TBX1 protein binding sites using ATAC-seq and ChIP-seq from embryo tissue. Preliminary data
suggests that we are able to identify direct transcriptional target genes. By these three aims, we
will understand the molecular functions of TBX1 in the progression of progenitor cells to more
differentiated states to build the cardiac outflow tract.
TBX1编码心脏发育所需的T-box转录因子。这个基因地图
Digeorge综合征/Velo-Cardio-患者删除的22q11.2染色体区域
面部综合征或22Q11.2缺失综合征(22q11.2ds)。大约22q11.2ds的60%
患者患有先天性心脏病,主要影响心脏流出道。一个子集
患有TBX1基因突变但没有缺失的个体已被鉴定出来,他们
部分22q11.2ds的表观复制患者。小鼠中TBX1等位基因的失活导致
轻度缺陷,但两个等位基因的失活会导致新生儿致死性,并持续
动脉,主动脉和肺部躯干无法分离。该缺陷也发生在5-
在22q11.2ds患有先天性心脏病的患者中,有10%。了解tbx1在
哺乳动物,我们进行了心咽的单细胞RNA-sequest(SCRNA-SEQ)
中胚层祖细胞中的咽室内。我们发现了一个多线
表达基因的祖先(MLP)种群对于形成心脏流出区很重要
以及面部和颈部的分支肌肉。 MLP人口在
当TBX1在心咽中灭活时,差异化的人群的费用更高
中胚层。我们的主要假设是MLP人群需要TBX1进行进展
迈向心脏发展所需的更明显的状态。我们提出了三个特定的
旨在检验这一假设。在第一个目标中,我们将执行其他SCRNA-SEQ实验
并分析完整的数据集,以了解如何改变MLP细胞的进展
TBX1条件和全局突变小鼠胚胎。在AIM 2中,我们将确定MLP的位置
细胞位于胚胎中。初步数据表明,这些细胞位于
伸长咽部装置的新生间充质。我们还将灭活tbx1
特别是在MLP细胞内确定其特定功能。在AIM 3中,我们将转向
功能性基因组研究,并将识别开放式染色质,该染色质为此提供
TBX1蛋白结合位点使用胚胎组织的ATAC-SEQ和CHIP-SEQ。初步数据
表明我们能够识别直接的转录靶基因。通过这三个目标,我们
将了解祖细胞进展中TBX1的分子功能
差异化状态以建立心脏流出区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BERNICE E MORROW其他文献
BERNICE E MORROW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BERNICE E MORROW', 18)}}的其他基金
Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
神经嵴和第二心野细胞介导先天性心脏病的分子发病机制
- 批准号:
10621288 - 财政年份:2022
- 资助金额:
$ 60.56万 - 项目类别:
Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome
22q11.2缺失综合征先天性心脏病的遗传修饰
- 批准号:
10373375 - 财政年份:2022
- 资助金额:
$ 60.56万 - 项目类别:
Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome
22q11.2缺失综合征先天性心脏病的遗传修饰
- 批准号:
10553279 - 财政年份:2022
- 资助金额:
$ 60.56万 - 项目类别:
Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
神经嵴和第二心野细胞介导先天性心脏病的分子发病机制
- 批准号:
10435713 - 财政年份:2022
- 资助金额:
$ 60.56万 - 项目类别:
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
心脏流出道形成和缺陷的分子和细胞机制
- 批准号:
10289982 - 财政年份:2021
- 资助金额:
$ 60.56万 - 项目类别:
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
心脏流出道形成和缺陷的分子和细胞机制
- 批准号:
10471433 - 财政年份:2021
- 资助金额:
$ 60.56万 - 项目类别:
Cell fate choices by Tbx1 in forming the mammalian heart
Tbx1 在形成哺乳动物心脏过程中的细胞命运选择
- 批准号:
10615781 - 财政年份:2020
- 资助金额:
$ 60.56万 - 项目类别:
相似国自然基金
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
- 批准号:82370906
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
22q11.2微缺失综合症中T盒转录因子Tbx1与信号接头蛋白Crkl遗传相互作用致肺动脉发育不良缺陷的机制研究
- 批准号:81170153
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于染色体22q11.2候选基因与腭心面综合征表型的分子诊断研究
- 批准号:81070813
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
无22q11.2区基因微缺失的心脏圆锥动脉干畸形患者中新TBX1突变体蛋白的功能研究
- 批准号:81070135
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
染色体22q11.2区域泌尿系统畸形关键致病基因的克隆与鉴定
- 批准号:30571867
- 批准年份:2005
- 资助金额:25.0 万元
- 项目类别:面上项目
相似海外基金
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
心脏流出道形成和缺陷的分子和细胞机制
- 批准号:
10289982 - 财政年份:2021
- 资助金额:
$ 60.56万 - 项目类别:
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
心脏流出道形成和缺陷的分子和细胞机制
- 批准号:
10471433 - 财政年份:2021
- 资助金额:
$ 60.56万 - 项目类别:
Cell fate choices by Tbx1 in forming the mammalian heart
Tbx1 在形成哺乳动物心脏过程中的细胞命运选择
- 批准号:
10242828 - 财政年份:2020
- 资助金额:
$ 60.56万 - 项目类别:
Cell fate choices by Tbx1 in forming the mammalian heart
Tbx1 在形成哺乳动物心脏过程中的细胞命运选择
- 批准号:
10034059 - 财政年份:2020
- 资助金额:
$ 60.56万 - 项目类别:
Olfactory and facial markers of developmental risk for psychosis in 22q11 deletion syndrome
22q11 缺失综合征精神病发育风险的嗅觉和面部标记
- 批准号:
10217017 - 财政年份:2019
- 资助金额:
$ 60.56万 - 项目类别: